Clinical Ophthalmology
Volume 11, 2017 - Issue
Open access
106
Views
19
CrossRef citations to date
0
Altmetric
Original Research
Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy
Arash Maleki1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham
, Neerav Lamba1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham
, Lina Ma1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham
, Stacey Lee1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham
, Alexander Schmidt1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham
& C Stephen Foster1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham;3 Harvard Medical School, Boston, MA, USACorrespondence[email protected]
Pages 377-385
|
Published online: 17 Feb 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.